CTIX Upcoming Presentations:

1. The 23rd Annual Newsmakers in the Biotech Industry

Friday, September 9, 9-9:30 AM

http://www.biocentury.com/data/newscenter2/co...hedule.pdf

2. Prurisol, a New Small Molecule to Treat Psoriasis, Completed Phase 2 Trial and now Geared up for Phase 3

• Strategy and science behind breakthrough oral small molecule, which is an immune-modulator affecting IL-20 and PRINS
• Lessons from discovery and early development, opening up a new pathway to treat psoriasis
• Obtaining a 505B(2) pathway; Key challenges and lessons on how this innovative small molecule was developed

Monday, September 19, 9:30 AM

Krishna Menon, Ph.D., President and Chief Scientific Officer, Cellceutix Corporation

3. Understanding Mechanisms, Novel Targets and Pathways to Further Novel Therapeutic Development in Dermatology

Monday, September 19, 10:05 AM

Krishna Menon, Ph.D., President and Chief Scientific Officer, Cellceutix Corporation

4. Utilizing New Tech for Med Derm Research and Development

• Biomarkers, Diagnostics, Imaging
• Target Engagement
• Skin Pharmacokinetics (PK)

Monday, September 19, 12:55 PM

Krishna Menon, Ph.D., President and Chief Scientific Officer, Cellceutix Corporation

5. Understanding Key Challenges and Special Considerations of Dermatology Drug Development

Monday, September 19, 2:10 PM

Krishna Menon, Ph.D., President and Chief Scientific Officer, Cellceutix Corporation

http://www.discoveryontarget.com/uploadedFile...ochure.pdf